Outcome of Newborn’s Gestational Age at 34-36 Weeks Whose Mothers were Diagnosed with Premature Rupture of Membranes: Comparison between Induction and Expectant Management

Main Article Content

Kannikar Booranavanich
Pichada Saengrat

Abstract

Objectives: To compare neonatal outcomes of preterm newborns of with a gestational age of 34 -36 week, whose mothers were diagnosed with premature rupture of membranes between the induction of labor and the expectant management group. Primary outcome was neonatal sepsis.


Methods: This was a retrospective study. The data were collected from preterm newborns of gestational age 34 -36 weeks, whose mothers were diagnosed with premature rupture of membranes at Vajira Hospital from 1st January 2011 to 31th December 2015


Results: 189 newborns were included in this study. There were 89 newborns in the induction management group and 100 newborns in the expectant management group. The reference group was the expectant management group. Neonatal sepsis was seen in 27% in the induction management group versus 61% in expectant management group. (Odds ratio 0.45, 95%CI 0.31-0.65, p-value <0.001) In addition, newborns in the expectant group had significant lower birth weight and lower median gestational age than newborns in induction groups. However, multivariate analysis, which adjusted for factors associated with neonatal sepsis, showed no significance between the two groups in primary and secondary outcomes.


Conclusion: Expectant management in case of newborns whose mothers were diagnosed with premature rupture of membranes at gestational age 34-36 weeks were more affected by neonatal sepsis than the induction management group. Due to the results of this study, newborns in the expectant group had lower birth weight and lower median gestational age than newborns in induction groups. The results of this study can be used to improve quality of care and raise awareness of preterm PROM in expectant management.

Article Details

How to Cite
Booranavanich, K., & Saengrat, P. (2018). Outcome of Newborn’s Gestational Age at 34-36 Weeks Whose Mothers were Diagnosed with Premature Rupture of Membranes: Comparison between Induction and Expectant Management. Vajira Medical Journal : Journal of Urban Medicine, 62(1), 21–32. Retrieved from https://he02.tci-thaijo.org/index.php/VMED/article/view/195774
Section
Original Articles

References

1. Alexander JM, Cox SM. Clinical course of premature rupture of the membranes. Semin Perinatol. 1996; 20(5):369-74.

2. Medina TM, Hill AD. Preterm premature rupture of membranes: diagnosis and management Am Fam Physician. 2006;73(4): 659-64.

3. Schuchat A, Zywicki SS, Dinsmoor MJ, Mercer B, Romaguera J, Sullivan MJ, et al. Risk factors and opportunities for prevention of early-onset neonatal sepsis: a multicenter case-control study. Pediatrics. 2000; 105:21-6.

4. Schrag SJ, Hadler JL, Arnold KE, Martell- Cleary P, Reingold AE, Schuchat A, et al. Risk factors for invasive, early-onset Escherichia coli infections in the era of widespread intrapartum antibiotic use. Pediatrics. 2006;118(2):570-6.

5. Spinillo A, Capuzzo E, Stronati M, Ometto A, Orcesi S, Fazzi E. Effect of preterm premature rupture of membranes on neurodevelopmental outcome: follow up at two years of age. Br J Obstet Gynaecol. 1995;102(11):882-7

6. The American College of Obstetricians and Gynecologists. Premature rupture of membranes. Practice bulletin. 2016;128(4): e165–77.

7. Buchanan SL, Crowther CA, Levett KM, Middleton P, Morris J. Planned early birth versus expectant management for women with preterm prelabor rupture of membranes prior to 37 weeks' gestation for improving pregnancy outcome. Cochrane Database Syst Rev. 2010;(3):CD004735.

8. Van der Ham DP, Vijgen SMC, Nijhuis JG, Van Beek JJ, Opmeer BC, Moonen R, et al . Induction of Labor versus Expectant Management in Women with Preterm Prelabor Rupture of Membranes between 34 and 37 Weeks: A Randomized Controlled Trial. PLoS Medicine.2012; 9(4): e1001208.

9. Van Der Ham DP, Van der Heyden JL, Opmeer BC, Mulder AL, Moonen RM, Van Beek JH, et al. Management of late-preterm premature rupture of membranes: the PPROMEXIL-2 trial. Am J Obstet Gynecol. 2012;207(4): 276.e1-10.